Ultrahuman’s App Store ‘PowerPlugs’ launches with the Atrial Fibrillation (AFib) PowerPlug. The Ultrahuman Ring AIR is the first smart ring in the world to detect AFib
July 16, 2024
Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring
July 16, 2024 — Ultrahuman, a pioneer in wearable technology, launches PowerPlugs, a platform for individual apps and

Read More
A strategic deal to deliver virtual value-based cardiology care to health systems has been announced by the executive team at Guidehealth, a provider of AI-enabled healthcare services and Story Health, a digital company involved in specialty care delivery.
July 15, 2024
Strategic Deal to Deliver Virtual Value-based Cardiology Care Announced by Guidehealth and Story Health
July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a

Read More
Data show that applying AI to VCG data provides more consistent and reliable detection of atrial flutter
July 15, 2024
HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias
July 15, 2024 — HeartBeam, Inc., a medical technology company focused on transforming cardiac care through the power of

Read More
Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd.
July 15, 2024
Edwards Lifesciences to Acquire Innovalve
July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an

Read More
Dr Pankaj Garg
July 12, 2024
Artificial Intelligence Speeds Up Heart Scans, Leading to Efficiency and Improving Outcomes
July 12, 2024 — Researchers have developed a groundbreaking method for analyzing heart MRI scans with the help of

Read More
First implant of Amvia Sky in Canada performed at the Centre Hospitalier de l'Université de Montréal
July 11, 2024
Amvia Sky Launched in Canada, the World’s First Pacemaker Approved for LBBAP
July 11, 2024 — Dr. Fadi Mansour performed the first Canadian implant of BIOTRONIK’s newest pacemaker and CRT-P

Read More
Further expands HeartSciences extensive patent portfolio
July 11, 2024
HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction
July 11, 2024 — Heart Test Laboratories, Inc. an artificial intelligence (AI)-powered medical technology company

Read More
Medical device company R3 Vascular Inc., a developer of novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), has announced the appointment of Josh Smale as its Vice President of Global Clinical and Scientific Affairs.
July 11, 2024
R3 Vascular Appoints Josh Smale as Vice President of Global Clinical and Scientific Affairs
July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for

Read More
Findings from an observational analysis of ARISE-HF trial participants, newly-published in the Journal of the American College of Cardiology, JACC, shed light on the racial and ethnic disparities in diabetic cardiomyopathy (DbCM).
July 10, 2024
Study Calls for Targeted Strategies for Managing Diabetic Cardiomyopathy Across Racial, Ethnic Groups
July 10, 2024 — Findings from an observational analysis of ARISE-HF trial participants, newly-published in the Journal

Read More
the cardiology clinic of the future
By Stuart Long
July 10, 2024
Step Into the Cardiology Clinic of the Future: Bringing Virtual Cardiac Care Delivery and Virtual Telemetry to Life in Your Practice’s Clinical Workflows
In a room of 20 people, it’s likely that about 10 of them, or half, will presently have some form of cardiovascular

Read More
ProtheraCytes
July 10, 2024
CellProthera and BioCardia Collaborate on Successful Phase II Trial of ProtheraCytes for the Treatment of Acute Myocardial Infarction
July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues,

Read More
Patent covers brilaroxazine use for treating pulmonary hypertension (PH), pulmonary arterial hypertension (PAH) in any patients including treating PH in patients with chronic obstructive pulmonary disease (COPD) or sickle cell disease (SCD)
July 10, 2024
Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Hypertension
July 10, 2024 — Reviva Pharmaceuticals Holdings, Inc., a late-stage pharmaceutical company developing therapies that

Read More
Keith Churchwell, M.D., FAHA, has been named new volunteer president at the American Heart Association for fiscal year 2024-2025.
July 09, 2024
American Heart Association Announces New 2024-2025 National Volunteer Leaders
July 9, 2024 — The American Heart Association, celebrating 100 years of lifesaving service as the world’s leading

Read More
Counties tend to be more rural and socioeconomically disadvantaged
July 09, 2024
Almost Half of US Counties Have No Cardiologists Despite Higher Prevalence of CV Risk Factors, Mortality
July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet

Read More
The clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY Endovascular Robotic Surgical System
July 09, 2024
Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial
July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY

Read More
Vivek Reddy, MD
July 08, 2024
Pulsed Field Ablation Procedures Found Safe and Effective for Atrial Fibrillation Patients
July 8, 2024 — Pulsed field ablation (PFA) is safe for treating patients with common types of atrial fibrillation (AF

Read More
July 08, 2024
Webinar on Optimizing Structural Heart Workflows to Take Place Next Week
On July 16, Diagnostic and Interventional Cardiology will present a webinar on "Maximizing Structural Heart Workflows:

Read More
During the American Heart Association Basic Cardiovascular Sciences (BCVS) Scientific Sessions 2024 taking place in Chicago this week, two new, basic research studies in rodents (mice and rats) analyzed the impacts that alcohol may have on the heart.
July 05, 2024
New Research on Alcohol’s Impact on the Heart at American Heart Association Basic Cardiovascular Sciences Scientific Sessions 2024
July 24, 2024 — During the American Heart Association Basic Cardiovascular Sciences Scientific Sessions 2024, BCVS, 

Read More
Happy 4th from the DAIC team in Chicago
July 04, 2024
Happy 4th from the DAIC team
The DAIC team wishes you a safe and happy 4th of July!
Read More
Researchers call for monitoring of quality, outcomes in era of private equity ownership
July 03, 2024
Study: Private Equity Acquisitions in Cardiology on the Rise
July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94%

Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now